Ascendis Pharma Ownership 2024 | Who Owns Ascendis Pharma Now?
Institutional Ownership
106.47%
Insider Ownership
0.76%
Retail Ownership
-7.22%
Institutional Holders
213.00
Ascendis Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 17.77% | 18.23% | 10,108,400 | - | - | 1,378,583,592 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8.72% | 3.33% | 4,962,824 | 887,610 | 21.78% | 676,829,960 | Jun 30, 2024 |
| FMR LLC | 8.65% | 0.04% | 4,922,555 | -15,906 | -0.32% | 671,338,051 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 7.55% | 0.88% | 4,295,029 | -1,376,905 | -24.28% | 585,756,055 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.38% | 7.62% | 4,196,661 | 229,995 | 5.80% | 572,340,627 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 6.89% | 0.29% | 3,918,813 | 151,610 | 4.02% | 534,488,464 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.59% | 0.06% | 2,612,856 | -133,016 | -4.84% | 356,341,302 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 3.70% | 0.06% | 2,104,298 | -87,014 | -3.97% | 286,984,161 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 3.67% | 0.09% | 2,084,851 | 102,982 | 5.20% | 284,332,033 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.14% | 0.03% | 1,784,148 | 2,222 | 0.12% | 243,323,000 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.01% | 0.07% | 1,711,015 | 93,185 | 5.76% | 233,348,226 | Jun 30, 2024 |
| INVESCO LTD. | 1.95% | 0.03% | 1,106,449 | 141,786 | 14.70% | 150,897,515 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.44% | 0.21% | 820,512 | 611,000 | 291.63% | 111,901,427 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.32% | 7.63% | 750,000 | 225,000 | 42.86% | 102,285,000 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.29% | 5.20% | 734,284 | -19,748 | -2.62% | 100,141,652 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.17% | 3.47% | 664,307 | 156,355 | 30.78% | 90,598,189 | Jun 30, 2024 |
| SPYGLASS CAPITAL MANAGEMENT LLC | 1.17% | 6.62% | 662,888 | 48,781 | 7.94% | 90,404,665 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.16% | 0.02% | 660,662 | 605,496 | 1097.59% | 90,101,083 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 1.05% | 1.28% | 596,314 | 20,616 | 3.58% | 81,325,303 | Jun 30, 2024 |
| BROWN ADVISORY INC | 0.84% | 0.09% | 478,676 | -205,396 | -30.03% | 65,281,832 | Jun 30, 2024 |
Ascendis Pharma's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 17.77% of the company's total share outstanding, currently valued at $1.38B. The top 10 institutional shareholders own together 72.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| Q GLOBAL ADVISORS, LLC | 0.39% | 21.23% | 219,459 | -65,541 | -23.00% | 29,930,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 17.77% | 18.23% | 10,108,400 | - | - | 1,378,583,592 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.40% | 7.85% | 227,762 | 115,092 | 102.15% | 31,062,182 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.32% | 7.63% | 750,000 | 225,000 | 42.86% | 102,285,000 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.38% | 7.62% | 4,196,661 | 229,995 | 5.80% | 572,340,627 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 0.33% | 7.33% | 189,272 | 13,600 | 7.74% | 25,812,915 | Jun 30, 2024 |
| SPYGLASS CAPITAL MANAGEMENT LLC | 1.17% | 6.62% | 662,888 | 48,781 | 7.94% | 90,404,665 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.20% | 5.83% | 113,224 | 9,796 | 9.47% | 15,441,489 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.29% | 5.20% | 734,284 | -19,748 | -2.62% | 100,141,652 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.33% | 4.14% | 186,581 | 34,994 | 23.09% | 25,445,917 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.15% | 3.70% | 86,721 | 86,721 | 100.00% | 11,827,010 | Jun 30, 2024 |
| RESOLUTE CAPITAL ASSET PARTNERS LLC | 0.08% | 3.69% | 47,000 | - | - | 6,410,000 | Jun 30, 2024 |
| EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC | 0.04% | 3.49% | 24,862 | 11,223 | 82.29% | 3,390,680 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.17% | 3.47% | 664,307 | 156,355 | 30.78% | 90,598,189 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8.72% | 3.33% | 4,962,824 | 887,610 | 21.78% | 676,829,960 | Jun 30, 2024 |
| ARS INVESTMENT PARTNERS, LLC | 0.45% | 3.30% | 253,139 | -1,828 | -0.72% | 34,523,097 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.09% | 2.78% | 50,000 | 25,000 | 100.00% | 6,819,000 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.14% | 2.64% | 80,972 | -11,500 | -12.44% | 11,042,961 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.04% | 2.38% | 20,000 | 20,000 | 100.00% | 2,727,600 | Jun 30, 2024 |
| MATISSE CAPITAL | 0.06% | 2.34% | 34,729 | -811 | -2.28% | 4,736,341 | Jun 30, 2024 |
The largest Ascendis Pharma shareholder by % of total assets is Q GLOBAL ADVISORS, LLC. The company owns 219.46K shares of Ascendis Pharma (ASND), representing 21.23% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8.72% | 3.33% | 4,962,824 | 887,610 | 21.78% | 676,829,960 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.44% | 0.21% | 820,512 | 611,000 | 291.63% | 111,901,427 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.16% | 0.02% | 660,662 | 605,496 | 1097.59% | 90,101,083 | Jun 30, 2024 |
| FIL LTD | 0.78% | 0.06% | 442,508 | 431,781 | 4025.18% | 60,349,241 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.38% | 7.62% | 4,196,661 | 229,995 | 5.80% | 572,340,627 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.32% | 7.63% | 750,000 | 225,000 | 42.86% | 102,285,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.17% | 3.47% | 664,307 | 156,355 | 30.78% | 90,598,189 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 6.89% | 0.29% | 3,918,813 | 151,610 | 4.02% | 534,488,464 | Jun 30, 2024 |
| INVESCO LTD. | 1.95% | 0.03% | 1,106,449 | 141,786 | 14.70% | 150,897,515 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 0.21% | 0.02% | 121,594 | 121,594 | 100.00% | 16,583,000 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.54% | 0.20% | 307,073 | 120,952 | 64.99% | 41,878,616 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.40% | 7.85% | 227,762 | 115,092 | 102.15% | 31,062,182 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.83% | 0.03% | 473,449 | 111,389 | 30.77% | 64,568,975 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 3.67% | 0.09% | 2,084,851 | 102,982 | 5.20% | 284,332,033 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.18% | 0.35% | 101,100 | 101,100 | 100.00% | 13,788,018 | Jun 30, 2024 |
| SOROS FUND MANAGEMENT LLC | 0.18% | 0.24% | 100,000 | 96,568 | 2813.75% | 13,638,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.34% | 0.16% | 195,347 | 95,972 | 96.58% | 26,640,181 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.01% | 0.07% | 1,711,015 | 93,185 | 5.76% | 233,348,226 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.15% | 3.70% | 86,721 | 86,721 | 100.00% | 11,827,010 | Jun 30, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 0.29% | 0.06% | 163,110 | 76,908 | 89.22% | 22,245,000 | Jun 30, 2024 |
As of Jun 30 2024, Ascendis Pharma's largest institutional buyer is WESTFIELD CAPITAL MANAGEMENT CO LP. The company purchased 887.61K stocks of ASND, valued at $676.83M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 0.05% | 0.00% | 30,564 | -2,538,339 | -98.81% | 4,169,000 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 7.55% | 0.88% | 4,295,029 | -1,376,905 | -24.28% | 585,756,055 | Jun 30, 2024 |
| BROWN ADVISORY INC | 0.84% | 0.09% | 478,676 | -205,396 | -30.03% | 65,281,832 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.18% | 0.01% | 99,946 | -136,924 | -57.81% | 13,630,635 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.59% | 0.06% | 2,612,856 | -133,016 | -4.84% | 356,341,302 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.26% | 0.02% | 146,327 | -124,443 | -45.96% | 19,956,076 | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -119,720 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -109,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.25% | 0.06% | 142,165 | -108,327 | -43.25% | 19,378,000 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 3.70% | 0.06% | 2,104,298 | -87,014 | -3.97% | 286,984,161 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.47% | 0.05% | 264,571 | -81,615 | -23.58% | 36,082,205,000 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.32% | 0.01% | 181,029 | -80,000 | -30.65% | 24,688,735 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| Q GLOBAL ADVISORS, LLC | 0.39% | 21.23% | 219,459 | -65,541 | -23.00% | 29,930,000 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.01% | 0.00% | 3,091 | -64,453 | -95.42% | 421,550 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.49% | 0.04% | 281,537 | -58,581 | -17.22% | 38,396,016 | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -48,500 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.01% | 7,100 | -42,900 | -85.80% | 968,298 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.19% | 0.00% | 110,641 | -40,303 | -26.70% | 15,089,199 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.01% | 0.02% | 6,589 | -37,500 | -85.06% | 898,608 | Jun 30, 2024 |
As of Jun 30 2024, Ascendis Pharma's biggest institutional seller is T. ROWE PRICE INVESTMENT MANAGEMENT, INC.. The company sold -2.54M shares of ASND, valued at $4.17M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOOMIS SAYLES & CO L P | 0.21% | 0.02% | 121,594 | 121,594 | 100.00% | 16,583,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.18% | 0.35% | 101,100 | 101,100 | 100.00% | 13,788,018 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.11% | 0.05% | 60,000 | 60,000 | 100.00% | 8,182,800 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.10% | 0.01% | 54,748 | 54,748 | 100.00% | 7,466,532 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.08% | 0.01% | 44,918 | 44,918 | 100.00% | 6,125,917 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 0.06% | 0.43% | 36,157 | 36,157 | 100.00% | 4,931,092 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.06% | 0.02% | 33,375 | 33,375 | 100.00% | 4,551,682 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.05% | 0.00% | 30,296 | 30,296 | 100.00% | 4,131,769 | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 0.04% | 0.11% | 20,250 | 20,250 | 100.00% | 2,761,695 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.04% | 2.38% | 20,000 | 20,000 | 100.00% | 2,727,600 | Jun 30, 2024 |
| SIT INVESTMENT ASSOCIATES INC | 0.02% | 0.04% | 12,880 | 12,880 | 100.00% | 1,757,000 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.02% | 0.01% | 10,000 | 10,000 | 100.00% | 1,363,800 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.02% | 0.00% | 9,100 | 9,100 | 100.00% | 1,241,058 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.02% | 0.08% | 8,877 | 8,877 | 100.00% | 1,210,645 | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | 0.01% | 0.01% | 6,080 | 6,080 | 100.00% | 829,190 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.01% | 0.00% | 4,932 | 4,932 | 100.00% | 672,626 | Jun 30, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 0.01% | 0.00% | 4,635 | 4,635 | 100.00% | 632,121 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.01% | 0.00% | 4,221 | 4,221 | 100.00% | 575,660 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 4,000 | 4,000 | 100.00% | 545,520 | Jun 30, 2024 |
| ADVISORS ASSET MANAGEMENT, INC. | 0.01% | 0.01% | 3,848 | 3,848 | 100.00% | 524,790 | Jun 30, 2024 |
| DNB ASSET MANAGEMENT AS | 0.01% | 0.00% | 3,347 | 3,347 | 100.00% | 456,464 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.01% | 0.00% | 2,833 | 2,833 | 100.00% | 393,000 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.00% | 0.01% | 2,502 | 2,502 | 100.00% | 341,223 | Jun 30, 2024 |
| TAIKANG ASSET MANAGEMENT (HONG KONG) CO LTD | 0.00% | 0.05% | 2,500 | 2,500 | 100.00% | 340,950 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.00% | 0.00% | 2,037 | 2,037 | 100.00% | 277,806 | Jun 30, 2024 |
| GUGGENHEIM CAPITAL LLC | 0.00% | 0.00% | 1,814 | 1,814 | 100.00% | 247,393 | Jun 30, 2024 |
| SEARLE & CO. | 0.00% | 0.05% | 1,500 | 1,500 | 100.00% | 204,570 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 141 | 141 | 100.00% | 20,369 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | 0.00% | 66 | 66 | 100.00% | 9,977 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 50 | 50 | 100.00% | 6,819 | Jun 30, 2024 |
| J.SAFRA ASSET MANAGEMENT CORP | - | 0.00% | 11 | 11 | 100.00% | 1,500 | Jun 30, 2024 |
Ascendis Pharma's largest new institutional shareholder by number of shares is LOOMIS SAYLES & CO L P, purchased 121.59K shares, valued at $16.58M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BARCLAYS PLC | - | - | - | -119,720 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -109,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -48,500 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -33,661 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -24,151 | -100.00% | - | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | - | - | - | -19,412 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -12,754 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -6,564 | -100.00% | - | Jun 30, 2024 |
| AXS INVESTMENTS LLC | - | - | - | -6,000 | -100.00% | - | Jun 30, 2024 |
| FORA CAPITAL, LLC | - | - | - | -4,649 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -4,500 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -4,300 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -3,900 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -2,400 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -1,875 | -100.00% | - | Jun 30, 2024 |
| PINPOINT ASSET MANAGEMENT LTD | - | - | - | -1,698 | -100.00% | - | Jun 30, 2024 |
| CM WEALTH ADVISORS LLC | - | - | - | -1,674 | -100.00% | - | Jun 30, 2024 |
| HC ADVISORS, LLC | - | - | - | -1,479 | -100.00% | - | Jun 30, 2024 |
| ICAPITAL WEALTH LLC | - | - | - | -1,451 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -1,448 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -1,406 | -100.00% | - | Jun 30, 2024 |
| PRIVATE OCEAN, LLC | - | - | - | -241 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -193 | -100.00% | - | Jun 30, 2024 |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
Ascendis Pharma's largest sold out institutional shareholder by shares sold is BARCLAYS PLC, sold -0.12M shares, valued at -, as of undefined.
Ascendis Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 1.84% | 301,003 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 1.28% | 12,937,000 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 1.04% | 10,437,000 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.84% | 130,480 | - | - | Jan 31, 2024 |
| HSBC FUNDS | 0.44% | 14,297 | - | - | Jan 31, 2024 |
| MFS SERIES TRUST IV | 0.34% | 1,169,326 | -4,013 | -0.34% | Feb 29, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.31% | 509,262 | -63,194 | -11.04% | Feb 29, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.23% | 55,730 | - | - | Dec 31, 2023 |
| Tema ETF Trust | 0.20% | 8,804 | 5,890 | 202.13% | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.19% | 618,037 | 298,833 | 93.62% | Mar 31, 2024 |
| ALGER FUNDS | 0.17% | 160,917 | -36,283 | -18.40% | Jan 31, 2024 |
| Capital Group Growth ETF | 0.16% | 60,652 | 10,852 | 21.79% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.15% | 734,347 | -41,800 | -5.39% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.12% | 1,024,825 | -46,907 | -4.38% | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.11% | 92,961 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.10% | 45,830 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.08% | 308,415 | -181,527 | -37.05% | Mar 31, 2024 |
| Clough Global Equity Fund | 0.08% | 4,800 | - | - | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.07% | 104,473 | -12,196 | -10.45% | Jan 31, 2024 |
| ALGER FUNDS II | 0.07% | 15,214 | - | - | Jan 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.06% | 19,960 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.06% | 478,174 | -48,137 | -9.15% | Jan 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.05% | 748,900 | -393,000 | -34.42% | Mar 31, 2024 |
| GROWTH FUND OF AMERICA | 0.04% | 1,063,909 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 110,000 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.04% | 78,854 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.03% | 25,370 | 25,370 | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 43,509 | 6,786 | 18.48% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.03% | 273,789 | -161,142 | -37.05% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,515,509 | -80,000 | -5.01% | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.02% | 8,700 | - | - | Jan 31, 2024 |
| NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST | 0.02% | 40,000 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.02% | 149,165 | -115,335 | -43.60% | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.02% | 4,892 | - | - | Dec 31, 2023 |
| REYNOLDS FUNDS INC | 0.02% | 200 | 200 | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.02% | 405,624 | 31,446 | 8.40% | Jan 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.02% | 150,000 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,288,069 | -978 | -0.08% | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 7,080 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.01% | 8,548 | -400 | -4.47% | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 410,057 | 4,238 | 1.04% | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.01% | 626,431 | - | - | Jan 31, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 46,081 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 579,165 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 2,470,292 | 170,247 | 7.40% | Dec 31, 2023 |
| INVESCO BLDRS INDEX FUNDS TRUST | 0.01% | 402 | - | - | Dec 31, 2022 |
| PUTNAM INVESTMENT FUNDS | 0.01% | 33,825 | -10,297 | -23.34% | Jan 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.01% | 221,012 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.01% | 600 | 400 | 200.00% | Feb 29, 2024 |
| Brown Advisory Funds | 0.01% | 207,333 | 38,992 | 23.16% | Mar 31, 2024 |
| Innovator ETFs Trust | 0.01% | 22,648 | 22,648 | - | Jan 31, 2024 |
| MFS SERIES TRUST I | 0.00% | 96,354 | 27,792 | 40.54% | Feb 29, 2024 |
| AB CAP FUND, INC. | 0.00% | 165,872 | -30,028 | -15.33% | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 240,000 | - | - | Mar 31, 2024 |
| TOUCHSTONE STRATEGIC TRUST | 0.00% | 288,036 | -28 | -0.01% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 14,109 | 217 | 1.56% | Feb 29, 2024 |
| AMG FUNDS | 0.00% | 120,300 | -30,540 | -20.25% | Mar 28, 2024 |
| GEORGE PUTNAM BALANCED FUND | 0.00% | 31,819 | -13,664 | -30.04% | Jan 31, 2024 |
| BARON SELECT FUNDS | 0.00% | 35,306 | - | - | Mar 31, 2024 |
| Oaktree Diversified Income Fund Inc. | 0.00% | 11,000 | 11,000 | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.00% | 141,082 | -441 | -0.31% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 678,000 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 83,851 | -1,704 | -1.99% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 91,663 | -97,097 | -51.44% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 32,406 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 60,000 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 35,271 | - | - | Feb 29, 2024 |
| Harbor ETF Trust | 0.00% | 10,870 | 993 | 10.05% | Jan 31, 2024 |
| Forward Funds | 0.00% | 4,500 | - | - | Sep 30, 2022 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 247,000 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 16,125 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,331 | -2,552 | -37.08% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 2,716 | -652 | -19.36% | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 57,637 | 8,190 | 16.56% | Mar 31, 2024 |
| ANCHOR SERIES TRUST | 0.00% | 56,860 | 385 | 0.68% | Sep 30, 2021 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 193,000 | - | - | Feb 29, 2024 |
| Virtus Strategy Trust | 0.00% | 34,000 | - | - | Mar 28, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 57,749 | 3,926 | 7.29% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 50,700 | -14,670 | -22.44% | Mar 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 2,235,563 | -52,831 | -2.31% | Mar 31, 2024 |
| NEXPOINT FUNDS I | 0.00% | 5,000 | - | - | Dec 31, 2023 |
| Calvert Responsible Index Series, Inc. | 0.00% | 2,123 | - | - | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 209,083 | - | - | Jan 31, 2024 |
| Oaktree Diversified Income Fund Inc. | 0.00% | 4,000 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 10,527 | -14,080 | -57.22% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.00% | 3,838 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 11,105 | -400 | -3.48% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 265,000 | -140,000 | -34.57% | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 14,312 | -7,988 | -35.82% | Feb 29, 2024 |
| Putnam ETF Trust | 0.00% | 8,489 | -3,926 | -31.62% | Feb 29, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 27,662 | 510 | 1.88% | Dec 31, 2023 |
| VANGUARD WHITEHALL FUNDS | 0.00% | 65,250 | - | - | Jan 31, 2024 |
| T. Rowe Price Balanced Fund, Inc. | 0.00% | 11,595 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 3,602 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 36,667 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 64,147 | 611 | 0.96% | Mar 28, 2024 |
| Columbia ETF Trust II | 0.00% | 3,697 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 2,308 | -620 | -21.17% | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 47,599 | 430 | 0.91% | Jan 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 6,000 | 6,000 | - | Mar 31, 2024 |
Ascendis Pharma's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 301.00K shares, compromising 1.84% of its total assets.
Ascendis Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 213 | 4.93% |
| 31 Mar, 24 | 203 | 1.50% |
| 31 Dec, 23 | 200 | 16.28% |
| 30 Sep, 23 | 172 | -0.58% |
| 30 Jun, 23 | 173 | -2.26% |
| 31 Mar, 23 | 177 | -12.38% |
| 31 Dec, 22 | 202 | 2.54% |
| 30 Sep, 22 | 197 | 13.22% |
| 30 Jun, 22 | 174 | -9.38% |
| 31 Mar, 22 | 192 | 4.35% |
| 31 Dec, 21 | 184 | - |
| 30 Sep, 21 | 184 | 0.55% |
| 30 Jun, 21 | 183 | -5.18% |
| 31 Mar, 21 | 193 | 3.76% |
| 31 Dec, 20 | 186 | 14.11% |
| 30 Sep, 20 | 163 | -1.21% |
| 30 Jun, 20 | 165 | 6.45% |
| 31 Mar, 20 | 155 | 1.97% |
| 31 Dec, 19 | 152 | 10.95% |
| 30 Sep, 19 | 137 | -3.52% |
| 30 Jun, 19 | 142 | -11.80% |
| 31 Mar, 19 | 161 | 43.75% |
| 31 Dec, 18 | 112 | 10.89% |
| 30 Sep, 18 | 101 | -3.81% |
| 30 Jun, 18 | 105 | 17.98% |
| 31 Mar, 18 | 89 | 36.92% |
| 31 Dec, 17 | 65 | 10.17% |
| 30 Sep, 17 | 59 | 73.53% |
| 30 Jun, 17 | 34 | -8.11% |
| 31 Mar, 17 | 37 | 19.35% |
| 31 Dec, 16 | 31 | 40.91% |
| 30 Sep, 16 | 22 | -8.33% |
| 30 Jun, 16 | 24 | -7.69% |
| 31 Mar, 16 | 26 | 8.33% |
| 31 Dec, 15 | 24 | -7.69% |
| 30 Sep, 15 | 26 | -18.75% |
| 30 Jun, 15 | 32 | -11.11% |
| 31 Mar, 15 | 36 | - |
As of 30 Jun 24, 213 institutions are holding Ascendis Pharma's shares, representing an increase of 4.93% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 60,561,767 | -0.18% |
| 31 Mar, 24 | 60,669,584 | 0.76% |
| 31 Dec, 23 | 60,209,519 | -0.07% |
| 30 Sep, 23 | 60,251,963 | -1.46% |
| 30 Jun, 23 | 61,145,392 | 0.27% |
| 31 Mar, 23 | 60,981,912 | -7.47% |
| 31 Dec, 22 | 65,905,848 | -1.18% |
| 30 Sep, 22 | 66,695,738 | 5.53% |
| 30 Jun, 22 | 63,202,755 | 1.96% |
| 31 Mar, 22 | 61,987,090 | 6.19% |
| 31 Dec, 21 | 58,373,523 | 0.64% |
| 30 Sep, 21 | 58,005,024 | 5.40% |
| 30 Jun, 21 | 55,035,448 | 3.99% |
| 31 Mar, 21 | 52,921,420 | -2.68% |
| 31 Dec, 20 | 54,377,492 | 1.36% |
| 30 Sep, 20 | 53,648,117 | 11.18% |
| 30 Jun, 20 | 48,252,127 | 0.46% |
| 31 Mar, 20 | 48,030,321 | 3.96% |
| 31 Dec, 19 | 46,201,505 | 0.17% |
| 30 Sep, 19 | 46,123,559 | -3.23% |
| 30 Jun, 19 | 47,663,417 | 3.58% |
| 31 Mar, 19 | 46,016,119 | 14.74% |
| 31 Dec, 18 | 40,105,469 | -0.21% |
| 30 Sep, 18 | 40,188,315 | 1.56% |
| 30 Jun, 18 | 39,572,763 | 3.79% |
| 31 Mar, 18 | 38,126,384 | 24.95% |
| 31 Dec, 17 | 30,513,359 | 6.04% |
| 30 Sep, 17 | 28,774,674 | 23.66% |
| 30 Jun, 17 | 23,269,447 | 10.36% |
| 31 Mar, 17 | 21,085,472 | 2.55% |
| 31 Dec, 16 | 20,561,240 | 46.91% |
| 30 Sep, 16 | 13,995,656 | 0.86% |
| 30 Jun, 16 | 13,876,640 | 15.29% |
| 31 Mar, 16 | 12,036,674 | 19.28% |
| 31 Dec, 15 | 10,090,990 | 12.58% |
| 30 Sep, 15 | 8,963,331 | 0.11% |
| 30 Jun, 15 | 8,953,630 | 5.61% |
| 31 Mar, 15 | 8,478,072 | - |
Ascendis Pharma (ASND) has 60.56M shares outstanding as of 30 Jun 24, down -0.18% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 106.47% | 0.94% |
| 31 Mar, 24 | 106.66% | 0.94% |
| 31 Dec, 23 | 106.35% | 0.93% |
| 30 Sep, 23 | 107.07% | 0.91% |
| 30 Jun, 23 | 108.76% | 0.92% |
| 31 Mar, 23 | 108.72% | 0.79% |
| 31 Dec, 22 | 117.54% | 0.82% |
| 30 Sep, 22 | 119.46% | 0.93% |
| 30 Jun, 22 | 113.26% | 0.95% |
| 31 Mar, 22 | 109.29% | 0.96% |
| 31 Dec, 21 | 106.58% | 0.95% |
| 30 Sep, 21 | 106.16% | 1.02% |
| 30 Jun, 21 | 102.20% | 1.05% |
| 31 Mar, 21 | 98.44% | 0.85% |
| 31 Dec, 20 | 107.43% | 1.04% |
| 30 Sep, 20 | 101.77% | 1.02% |
| 30 Jun, 20 | 100.09% | 1.00% |
| 31 Mar, 20 | 100.09% | 1.01% |
| 31 Dec, 19 | 99.34% | 1.06% |
| 30 Sep, 19 | 96.92% | 0.95% |
| 30 Jun, 19 | 101.00% | 0.90% |
| 31 Mar, 19 | 106.10% | 1.11% |
| 31 Dec, 18 | 97.62% | 1.06% |
| 30 Sep, 18 | 95.94% | 1.06% |
| 30 Jun, 18 | 95.01% | 0.98% |
| 31 Mar, 18 | 98.52% | 1.20% |
| 31 Dec, 17 | 90.74% | 1.17% |
| 30 Sep, 17 | 88.25% | 1.72% |
| 30 Jun, 17 | 71.59% | 1.69% |
| 31 Mar, 17 | 65.02% | 1.09% |
| 31 Dec, 16 | 77.40% | 2.51% |
| 30 Sep, 16 | 55.55% | 1.81% |
| 30 Jun, 16 | 55.36% | 2.39% |
| 31 Mar, 16 | 48.10% | 2.65% |
| 31 Dec, 15 | 42.61% | 3.15% |
| 30 Sep, 15 | 36.79% | 2.61% |
| 30 Jun, 15 | 37.51% | 2.39% |
| 31 Mar, 15 | 39.65% | - |
As of 30 Jun 24, Ascendis Pharma is held by 106.47% institutional shareholders, representing a 0.94% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 109 | -1.80% |
| 31 Mar, 24 | 111 | 11.00% |
| 31 Dec, 23 | 100 | 38.89% |
| 30 Sep, 23 | 72 | -20.88% |
| 30 Jun, 23 | 91 | 18.18% |
| 31 Mar, 23 | 77 | -21.43% |
| 31 Dec, 22 | 98 | -4.85% |
| 30 Sep, 22 | 103 | 24.10% |
| 30 Jun, 22 | 83 | -12.63% |
| 31 Mar, 22 | 95 | -2.06% |
| 31 Dec, 21 | 97 | -6.73% |
| 30 Sep, 21 | 104 | 7.22% |
| 30 Jun, 21 | 97 | -11.82% |
| 31 Mar, 21 | 110 | 7.84% |
| 31 Dec, 20 | 102 | 7.37% |
| 30 Sep, 20 | 95 | 1.06% |
| 30 Jun, 20 | 94 | 36.23% |
| 31 Mar, 20 | 69 | -24.18% |
| 31 Dec, 19 | 91 | 31.88% |
| 30 Sep, 19 | 69 | -5.48% |
| 30 Jun, 19 | 73 | -23.16% |
| 31 Mar, 19 | 95 | 93.88% |
| 31 Dec, 18 | 49 | -5.77% |
| 30 Sep, 18 | 52 | -8.77% |
| 30 Jun, 18 | 57 | -5.00% |
| 31 Mar, 18 | 60 | 50.00% |
| 31 Dec, 17 | 40 | -16.67% |
| 30 Sep, 17 | 48 | 128.57% |
| 30 Jun, 17 | 21 | 5.00% |
| 31 Mar, 17 | 20 | -16.67% |
| 31 Dec, 16 | 24 | 242.86% |
| 30 Sep, 16 | 7 | -61.11% |
| 30 Jun, 16 | 18 | 80.00% |
| 31 Mar, 16 | 10 | -9.09% |
| 31 Dec, 15 | 11 | -21.43% |
| 30 Sep, 15 | 14 | 7.69% |
| 30 Jun, 15 | 13 | -63.89% |
| 31 Mar, 15 | 36 | - |
109 institutional shareholders have increased their position in ASND stock as of 30 Jun 24 compared to 111 in the previous quarter (a -1.80% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 68 | 36.00% |
| 31 Mar, 24 | 50 | -23.08% |
| 31 Dec, 23 | 65 | -1.52% |
| 30 Sep, 23 | 66 | 15.79% |
| 30 Jun, 23 | 57 | -12.31% |
| 31 Mar, 23 | 65 | -9.72% |
| 31 Dec, 22 | 72 | 38.46% |
| 30 Sep, 22 | 52 | -14.75% |
| 30 Jun, 22 | 61 | - |
| 31 Mar, 22 | 61 | 15.09% |
| 31 Dec, 21 | 53 | 6.00% |
| 30 Sep, 21 | 50 | -1.96% |
| 30 Jun, 21 | 51 | -1.92% |
| 31 Mar, 21 | 52 | -1.89% |
| 31 Dec, 20 | 53 | 23.26% |
| 30 Sep, 20 | 43 | - |
| 30 Jun, 20 | 43 | -28.33% |
| 31 Mar, 20 | 60 | 30.43% |
| 31 Dec, 19 | 46 | 12.20% |
| 30 Sep, 19 | 41 | -8.89% |
| 30 Jun, 19 | 45 | 12.50% |
| 31 Mar, 19 | 40 | -2.44% |
| 31 Dec, 18 | 41 | 51.85% |
| 30 Sep, 18 | 27 | -3.57% |
| 30 Jun, 18 | 28 | 16.67% |
| 31 Mar, 18 | 24 | 71.43% |
| 31 Dec, 17 | 14 | 133.33% |
| 30 Sep, 17 | 6 | -14.29% |
| 30 Jun, 17 | 7 | -41.67% |
| 31 Mar, 17 | 12 | 200.00% |
| 31 Dec, 16 | 4 | -42.86% |
| 30 Sep, 16 | 7 | 133.33% |
| 30 Jun, 16 | 3 | -50.00% |
| 31 Mar, 16 | 6 | - |
| 31 Dec, 15 | 6 | -25.00% |
| 30 Sep, 15 | 8 | -33.33% |
| 30 Jun, 15 | 12 | - |
| 31 Mar, 15 | - | - |
68 institutional shareholders have reduced their position in ASND stock as of 30 Jun 24 compared to 50 in the previous quarter (a 36.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 213 | 4.93% | 60,561,767 | -0.18% | 106.47% | 0.94% | 109 | -1.80% | 68 | 36.00% |
| 31 Mar, 24 | 203 | 1.50% | 60,669,584 | 0.76% | 106.66% | 0.94% | 111 | 11.00% | 50 | -23.08% |
| 31 Dec, 23 | 200 | 16.28% | 60,209,519 | -0.07% | 106.35% | 0.93% | 100 | 38.89% | 65 | -1.52% |
| 30 Sep, 23 | 172 | -0.58% | 60,251,963 | -1.46% | 107.07% | 0.91% | 72 | -20.88% | 66 | 15.79% |
| 30 Jun, 23 | 173 | -2.26% | 61,145,392 | 0.27% | 108.76% | 0.92% | 91 | 18.18% | 57 | -12.31% |
| 31 Mar, 23 | 177 | -12.38% | 60,981,912 | -7.47% | 108.72% | 0.79% | 77 | -21.43% | 65 | -9.72% |
| 31 Dec, 22 | 202 | 2.54% | 65,905,848 | -1.18% | 117.54% | 0.82% | 98 | -4.85% | 72 | 38.46% |
| 30 Sep, 22 | 197 | 13.22% | 66,695,738 | 5.53% | 119.46% | 0.93% | 103 | 24.10% | 52 | -14.75% |
| 30 Jun, 22 | 174 | -9.38% | 63,202,755 | 1.96% | 113.26% | 0.95% | 83 | -12.63% | 61 | - |
| 31 Mar, 22 | 192 | 4.35% | 61,987,090 | 6.19% | 109.29% | 0.96% | 95 | -2.06% | 61 | 15.09% |
| 31 Dec, 21 | 184 | - | 58,373,523 | 0.64% | 106.58% | 0.95% | 97 | -6.73% | 53 | 6.00% |
| 30 Sep, 21 | 184 | 0.55% | 58,005,024 | 5.40% | 106.16% | 1.02% | 104 | 7.22% | 50 | -1.96% |
| 30 Jun, 21 | 183 | -5.18% | 55,035,448 | 3.99% | 102.20% | 1.05% | 97 | -11.82% | 51 | -1.92% |
| 31 Mar, 21 | 193 | 3.76% | 52,921,420 | -2.68% | 98.44% | 0.85% | 110 | 7.84% | 52 | -1.89% |
| 31 Dec, 20 | 186 | 14.11% | 54,377,492 | 1.36% | 107.43% | 1.04% | 102 | 7.37% | 53 | 23.26% |
| 30 Sep, 20 | 163 | -1.21% | 53,648,117 | 11.18% | 101.77% | 1.02% | 95 | 1.06% | 43 | - |
| 30 Jun, 20 | 165 | 6.45% | 48,252,127 | 0.46% | 100.09% | 1.00% | 94 | 36.23% | 43 | -28.33% |
| 31 Mar, 20 | 155 | 1.97% | 48,030,321 | 3.96% | 100.09% | 1.01% | 69 | -24.18% | 60 | 30.43% |
| 31 Dec, 19 | 152 | 10.95% | 46,201,505 | 0.17% | 99.34% | 1.06% | 91 | 31.88% | 46 | 12.20% |
| 30 Sep, 19 | 137 | -3.52% | 46,123,559 | -3.23% | 96.92% | 0.95% | 69 | -5.48% | 41 | -8.89% |
| 30 Jun, 19 | 142 | -11.80% | 47,663,417 | 3.58% | 101.00% | 0.90% | 73 | -23.16% | 45 | 12.50% |
| 31 Mar, 19 | 161 | 43.75% | 46,016,119 | 14.74% | 106.10% | 1.11% | 95 | 93.88% | 40 | -2.44% |
| 31 Dec, 18 | 112 | 10.89% | 40,105,469 | -0.21% | 97.62% | 1.06% | 49 | -5.77% | 41 | 51.85% |
| 30 Sep, 18 | 101 | -3.81% | 40,188,315 | 1.56% | 95.94% | 1.06% | 52 | -8.77% | 27 | -3.57% |
| 30 Jun, 18 | 105 | 17.98% | 39,572,763 | 3.79% | 95.01% | 0.98% | 57 | -5.00% | 28 | 16.67% |
| 31 Mar, 18 | 89 | 36.92% | 38,126,384 | 24.95% | 98.52% | 1.20% | 60 | 50.00% | 24 | 71.43% |
| 31 Dec, 17 | 65 | 10.17% | 30,513,359 | 6.04% | 90.74% | 1.17% | 40 | -16.67% | 14 | 133.33% |
| 30 Sep, 17 | 59 | 73.53% | 28,774,674 | 23.66% | 88.25% | 1.72% | 48 | 128.57% | 6 | -14.29% |
| 30 Jun, 17 | 34 | -8.11% | 23,269,447 | 10.36% | 71.59% | 1.69% | 21 | 5.00% | 7 | -41.67% |
| 31 Mar, 17 | 37 | 19.35% | 21,085,472 | 2.55% | 65.02% | 1.09% | 20 | -16.67% | 12 | 200.00% |
| 31 Dec, 16 | 31 | 40.91% | 20,561,240 | 46.91% | 77.40% | 2.51% | 24 | 242.86% | 4 | -42.86% |
| 30 Sep, 16 | 22 | -8.33% | 13,995,656 | 0.86% | 55.55% | 1.81% | 7 | -61.11% | 7 | 133.33% |
| 30 Jun, 16 | 24 | -7.69% | 13,876,640 | 15.29% | 55.36% | 2.39% | 18 | 80.00% | 3 | -50.00% |
| 31 Mar, 16 | 26 | 8.33% | 12,036,674 | 19.28% | 48.10% | 2.65% | 10 | -9.09% | 6 | - |
| 31 Dec, 15 | 24 | -7.69% | 10,090,990 | 12.58% | 42.61% | 3.15% | 11 | -21.43% | 6 | -25.00% |
| 30 Sep, 15 | 26 | -18.75% | 8,963,331 | 0.11% | 36.79% | 2.61% | 14 | 7.69% | 8 | -33.33% |
| 30 Jun, 15 | 32 | -11.11% | 8,953,630 | 5.61% | 37.51% | 2.39% | 13 | -63.89% | 12 | - |
| 31 Mar, 15 | 36 | - | 8,478,072 | - | 39.65% | - | 36 | - | - | - |
Ascendis Pharma Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| BGNE | BeiGene, Ltd. |
| REPL | Replimune Group, Inc. |
| KDNY | Chinook Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| ACLX | Arcellx, Inc. |
| ETNB | 89bio, Inc. |
| UTHR | United Therapeutics Corporation |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
ASND Ownership FAQ
Who Owns Ascendis Pharma?
Ascendis Pharma is owned by institutional shareholders (106.47%), insiders (0.76%), and public (-7.22%). The largest institutional shareholder of Ascendis Pharma is RA CAPITAL MANAGEMENT, L.P. (17.77% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.84% of total shares).
Who are the major institutional shareholders of Ascendis Pharma?
Ascendis Pharma's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, FMR LLC, ARTISAN PARTNERS LIMITED PARTNERSHIP, and AVORO CAPITAL ADVISORS LLC. The top five shareholders own together 50.08% of the company's share outstanding.
How many Ascendis Pharma shareholders are there?
As of Jun 2024, there are 213 institutional shareholders of Ascendis Pharma.
What percentage of Ascendis Pharma is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 10.11M shares of Ascendis Pharma, representing 17.77% of the company's total shares outstanding, valued at $1.38B (as of Jun 2024).
What percentage of Ascendis Pharma is owned by WESTFIELD CAPITAL MANAGEMENT CO LP?
As of Jun 2024, WESTFIELD CAPITAL MANAGEMENT CO LP holds 4.96M shares of Ascendis Pharma (ASND), compromising 8.72% of the company, valued at $676.83M.
What percentage of Ascendis Pharma is owned by FMR LLC?
FMR LLC is the third largest holder of Ascendis Pharma. The company owns 4.92M of the company's shares outstanding (worth $671.34M).